Cancer drugs capable of weakening the body’s immune defenses are no more likely to increase the risk of COVID-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows. Researchers say the results challenge initial concerns that such treatments, which poison cancer cells, were too dangerous to continue during the pandemic.